Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Deficit)
Beginning balances (in shares) at Dec. 31, 2019   36,876,000    
Beginning balances at Dec. 31, 2019 $ 52,809 $ 37 $ 60,742 $ (7,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon warrant exercise (in shares)   191,000    
Common stock issued upon warrant exercise 510   510  
Common stock issued upon cashless warrant exercise (in shares)   19,000    
Common stock issued upon cashless warrant exercise 0      
Common stock issued upon cashless exercise of options (in shares)   280,000    
Common stock issued upon cashless exercise of options 0      
Common stock issued in connection with business combinations (in shares)   250,000    
Common stock issued in connection with business combinations 1,102   1,102  
Common stock issued for assets (in shares)   24,000    
Common stock issued for assets 101   101  
Common stock issued for services (in shares)   50,000    
Common stock issued for services 0      
Common stock issued for share based compensation (in shares)   519,000    
Common stock issued for share based compensation 1,761 $ 1 1,760  
Share based compensation 2,209   2,209  
Net income (loss) (2,094)     (2,094)
Ending balances (in shares) at Mar. 31, 2020   38,209,000    
Ending balances at Mar. 31, 2020 56,398 $ 38 66,424 (10,064)
Beginning balances (in shares) at Dec. 31, 2019   36,876,000    
Beginning balances at Dec. 31, 2019 52,809 $ 37 60,742 (7,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 480      
Ending balances (in shares) at Jun. 30, 2020   38,846,000    
Ending balances at Jun. 30, 2020 61,930 $ 38 69,382 (7,490)
Beginning balances (in shares) at Mar. 31, 2020   38,209,000    
Beginning balances at Mar. 31, 2020 56,398 $ 38 66,424 (10,064)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon warrant exercise (in shares)   81,000    
Common stock issued upon warrant exercise 282   282  
Common stock issued upon cashless warrant exercise (in shares)   78,000    
Common stock issued upon cashless warrant exercise 0      
Common stock issued upon cashless exercise of options (in shares)   30,000    
Common stock issued upon cashless exercise of options 0      
Common stock issued in connection with business combinations (in shares)   108,000    
Common stock issued in connection with business combinations 705   705  
Common stock issued for assets (in shares)   10,000    
Common stock issued for assets 67   67  
Common stock issued for services (in shares)   325,000    
Common stock issued for services 717   717  
Common stock issued for share based compensation (in shares)   5,000    
Common stock issued for share based compensation 25   25  
Share based compensation 1,162   1,162  
Net income (loss) 2,574     2,574
Ending balances (in shares) at Jun. 30, 2020   38,846,000    
Ending balances at Jun. 30, 2020 61,930 $ 38 69,382 (7,490)
Beginning balances (in shares) at Dec. 31, 2020   57,151,000    
Beginning balances at Dec. 31, 2020 316,997 $ 57 319,582 (2,642)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon warrant exercise (in shares)   40,000    
Common stock issued upon warrant exercise 111   111  
Common stock issued upon cashless warrant exercise (in shares)   535,000    
Common stock issued upon cashless warrant exercise 0 $ 1 (1)  
Common stock issued upon exercise of options (in shares)   1,000    
Common stock issued upon exercise of options 2   2  
Common stock issued upon cashless exercise of options (in shares)   5,000    
Common stock issued upon cashless exercise of options 0      
Common stock issued in connection with business combinations (in shares)   548,000    
Common stock issued in connection with business combinations 29,249   29,249  
Common stock issued for share based compensation (in shares)   300,000    
Common stock issued for share based compensation 0      
Common stock redeemed in litigation settlement (in shares)   (90,000)    
Common stock redeemed in litigation settlement 0      
Common stock redemption (in shares)   (96,000)    
Common stock redemption (3,954)   (3,954)  
Share based compensation 1,187   1,187 0
Net income (loss) 6,147     6,147
Ending balances (in shares) at Mar. 31, 2021   58,394,000    
Ending balances at Mar. 31, 2021 349,739 $ 58 346,176 3,505
Beginning balances (in shares) at Dec. 31, 2020   57,151,000    
Beginning balances at Dec. 31, 2020 $ 316,997 $ 57 319,582 (2,642)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon exercise of options (in shares) 753,000      
Net income (loss) $ 12,860      
Ending balances (in shares) at Jun. 30, 2021   59,562,000    
Ending balances at Jun. 30, 2021 363,853 $ 60 353,575 10,218
Beginning balances (in shares) at Mar. 31, 2021   58,394,000    
Beginning balances at Mar. 31, 2021 349,739 $ 58 346,176 3,505
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued upon warrant exercise (in shares)   216,000    
Common stock issued upon warrant exercise 224   224  
Common stock issued upon cashless warrant exercise (in shares)   119,000    
Common stock issued upon cashless warrant exercise 0      
Common stock issued upon exercise of options (in shares)   460,000    
Common stock issued upon exercise of options 1,730 $ 1 1,729  
Common stock issued upon cashless exercise of options (in shares)   272,000    
Common stock issued upon cashless exercise of options 0      
Common stock issued in connection with business combinations (in shares)   101,000    
Common stock issued in connection with business combinations 3,939 $ 1 3,938  
Share based compensation 1,508   1,508  
Net income (loss) 6,713     6,713
Ending balances (in shares) at Jun. 30, 2021   59,562,000    
Ending balances at Jun. 30, 2021 $ 363,853 $ 60 $ 353,575 $ 10,218